David O’Reilly
David O’Reilly has over 25 years of experience as a consultant in the life sciences industry and in the founding, financing, scaling and partnering of innovative pharmaceutical and medical technology companies. He currently provides strategic advisory, product development and financing services to global life sciences companies, start-ups and investors.
He serves on the Board of Directors of Baymatob (a wearable sensor and analytics-based medtech company focused on maternal and fetal health), Bioliberty (a soft robotics-based medtech company focused on neurorehabilitation), Neupulse (a neuromodulation-based wearable device company focused on Tourette Syndrome) and The Health Trust (a nonprofit operating foundation focused on health equity and access).
David has co-founded and held executive roles at several successful life sciences companies, including Proteus Digital Health, Catalyst Biosciences, Iconix Biosciences, ARIAD Pharmaceuticals and L.E.K. Consulting. David is an inventor on over a dozen issued and pending patents related to digital technologies and their application to drug discovery, therapeutic products and health care monitoring. He earned an MBA from Harvard Business School, where he graduated with Distinction, and a BA from Wesleyan University, where he was named the Gilbert H. Clee Scholar.
Location: San Francisco, CA
